Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interaction between HIV-1 integrase (IN) and lens epithelium-derived growth factor p75 (LEDGF/p75) is a critical molecular event in the life cycle of HIV-1. LEDGF/p75 acts as a cellular cofactor for HIV-1 integrase, facilitating the integration of viral DNA into the host genome—a key step required for productive infection. Targeting this interaction is considered a therapeutic strategy.
Disruption of the HIV-1 Integrase–LEDGF/p75 interaction by binding to the LEDGF pocket on integrase.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Immunodeficiency Virus type 1 Integrase–Lens Epithelium-Derived Growth Factor p75 Interaction.